In contrast, the N-terminal tau fragments (6 bands, 28–43 kDa) are detected at high levels across all patients (control, 27%, AD III/IV, 25% and AD V/VI, 20%, median values), with no obvious differences in pattern or apparent molecular weights across patient groups (Fig. 1c). The gene discussed is MAPT; the disease is Alzheimer disease.